NCT06216821View on ClinicalTrials.gov

OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time

NARecruitingINTERVENTIONAL
Enrollment

3,490

Participants

Timeline

Start Date

July 2, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
Acute Coronary Syndrome
Interventions
DRUG

standard DAPT

standard DAPT with aspirin and a P2Y12 inhibitor for 12 months after DES implantation.

DRUG

OPT-CAD score guided DAPT de-escalation

De-escalation DAPT at 3 months for moderate to high risk patients and de-escalation DAPT at 1 month for low risk patients.

Trial Locations (1)

110016

RECRUITING

General Hospital of Northern Theater Command, Shenyang

All Listed Sponsors
lead

Shenyang Northern Hospital

OTHER